March 26, 2013
The Center for Emerging and Innovative Sciences (CEIS) hosted its 13th annual University Technology Showcase at the Doubletree Hotel in Henrietta. The Showcase was an opportunity for university researchers to present their work to industry representatives, as well as to other researchers and organizations that promote economic development. The objective was to stimulate discussions that may lead to industry-university collaboration. The Showcase featured posters by investigators from the University of Rochester, Rochester Institute of Technology, and surrounding universities. In Rochester alone, there is over $400 million of sponsored research each year. Much of this research has industrial applications and is an opportunity for local businesses to gain awareness of some of the technology being developed which can lead to innovative new products and competitive advantages. For more information about this event, click here.
Siemens President and CEO Gregory Sorensen Presents, "Pursuing Innovation with PET-MRI in an Era of Value-Based Healthcare"
February 25, 2013
Siemens President and CEO Gregory Sorensen, MD, discussed how new payment models hinder technical innovation, and how smart companies are facing those challenges. His hour-long talk, titled “Pursuing Innovation with PET-MRI in an Era of Value-Based Healthcare,” focused on Biograph mMR, or PET-MRI technology. The special lecture was presented jointly by the Department of Imaging Sciences and Siemens Healthcare North America. For more information about this event, click here.
February 12, 2013
Changes to patent law take place on March 16, 2013 under the America Invents Act. The "first to invent" system we are all used to in the United States will switch over to a "first to file" system.
Kathryn Doyle , Ph.D., J.D., Partner and Chair of Riverside Law, discussed what these changes mean and if it makes sense to file before the changes take place, or after. For more information about this event, click here.
January 24, 2013
This meeting addressed:
- Linking medical technology to centralized EMR systems: What should component suppliers and the medical device community keep in mind when designing new technologies to operate within HIT systems?
- Initiatives and guidelines/standards from the NYS Department of Health and the US Department of Health and Human Services for integrating HIT with new medical devices
- How future computing and informatics tools will interface with large health systems data networks
- Dr. Joseph M. Jasinski, IBM Distinguished Engineer, Global Industry Executive, Smarter Healthcare and Life Sciences, IBM Research
- Dr. Thomas Furlani, Interim Associate Vice President for Information Technology (CIO), Director, Center for Computational Research, University at Buffalo
- Dr. Benjamin L. Miller, Health Sciences Center for Computational Innovation, University of Rochester Medical Center
- Dr. Gene D. Morse, Associate Director, NYS Center of Excellence in Bioinformatics and Life Sciences, Professor, Pharmacy Practice, Medicine and Pediatrics, University at Buffalo
- Dr. Peter Winkelstein, Executive Director, University at Buffalo Institute for Healthcare Informatics, Chief Medical Informatics Officer, UBMD
For more information about this event , click here.
HTR Growth Leadership Series: Protecting Proprietary Interests in the Medical Device and Life Science Industries
January 10, 2013
Biomedical innovation is at the epicenter of an expanding domestic and global market, yet taking advantage of this market often depends on the strength of a company's intellectual property (IP) portfolio and breadth of patent protection. The importance of IP protection cannot be understated.
Without a strong IP portfolio, it becomes exceedingly difficult for small businesses and start-ups to secure the funding necessary for growth and development. Complicating the matter is the cost of conforming to an evolving patent policy in the United States and abroad. This program featured presentations by senior executives at Empire Genomics and Diffinity Genomics, as well as attorneys from Phillips Lytle. The panelists shared their experiences and approaches for cost-efficient technology commercialization and sustainable business growth.
January 9, 2013
The Medical Scientist Research Symposium showcased the research and scientific accomplishments of the University of Rochester’s Medical Scientist Training Program. The 2013 Dr. Thomas A. and Joyce E. Pearson Endowed Lecturer was Anthony Atala, MD. Dr. Atala is the Director of the Wake Forest Institute for Regenerative Medicine, and the W.H. Boyce Professor and Chair of the Department of Urology at Wake Forest University. Dr. Atala is a practicing surgeon and a researcher in the area of regenerative medcine. His current work focuses on growing new human cells, tissues, and organs. For more informationa about this event, click here.
January 8, 2013
The Office of Technology Transfer, in cooperation with the Center for Entrepreneurship proudly presented F.I.R.E. in January: "The Future of Diagnostic and Gene Patenting." Carissa Childs, Ph.D., J.D., and Ted Merkel, J.D., spoke about recent court rulings that will impact current and future strategies surrounding diagnostic and gene-based technologies. Dr. Childs is an Associate and Mr. Merkel is a Shareholder at LeClairRyan. For more information about this event, please click here.
MedTech Partner Event: Cracking the Code on Healthcare - Embracing Innovation to Drive Revenue Growth
December 4, 2012
Professor Arie Orenstein, MD, focused on the bottom line and inspired the audience think differently about the business of health - about how organizations are innovating, marketing to their sweet spot, and uncovering new revenue opportunities. Yoni Stern shared the philosophy and methodologies for creating a culture of Innovation, and how the most successful companies and healthcare organizations around the world are embracing innovation to drive better bottom line results. For more information about this event, click here.
"Research and Education in a Data Intensive Era:" A Seminar by Dr. Cora B. Marrett, Deputy Director, National Science Foundation
November 28, 2012
On November 28th, Dr. Cora B. Marrett, Deputy Director of the National Science Foundation, presented "Research and Education in a Data Intensive Era." According to several sources, a data deluge increasingly marks science and engineering. The proliferation of often complex data provides challenges to the worlds of discovery and of education. These challenges are garnering ever greater attention from NSF (and other parts of the Federal government) in the context of "Big Data." Click here to read Dr. Marrett's bio.
November 14, 2012
Charles Spainhour, V.M.D., Ph.D., Chief Science Officer of Calvert Labs, discussed Calvert's laboratory services for pre-clinical testing of new drug and vaccine candidates. Click here for more information about this event.
October 26, 2012
Jesse Goodman, MD, MPH, Deputy Commissioner and Chief Science Officer at the FDA, presented "Advancing Regulatory Science to Protect and Promote Health." Click here to read Dr. Goodman's bio.
October 12, 2012
Recipients of the 2011 Provost’s Multidisciplinary Awards presented their latest research on topics such as social media in political campaigns, mobile phone–based asthma management for adolescents, new ways to diagnose traumatic brain injury, novel strategies in antimalarial drugs, and the perception of music and language. A reception to honor the recipients of the 2012 awards, as well as the 2011 presenters, followed. Click here for more information.
Innovative Aging Symposium: "Creating and Sustaining the Academic, Clinical, and Business Partnerships that Drive Innovation for Aging in Place"
October 11, 2012
SUNY Oswego Metro Center, IMPARA, and MedTech partnered to present keynote speaker Dr. Joe Coughlin (Director of the MIT Age Lab) and a panel of experts who discussed how new technologies can address the challenges posed by the global aging population, and how inventions that facilitate aging-in-place are translated into industrial or entrepreneurial development. There was also a technology showcase highlighting leading cross-sector partnerships and research, and exploring new products, prototypes, and adaptations of existing technology to new uses relevant to aging in place. Click here for more information about the symposium and technology showcase.
October 10, 2012
Understanding the processes for medical device reimbursements from health insurers is critical to determining addressable market adoption, as well as planning sales and channel strategies for new medical devices. Entrepreneurs need to consider this in planning product launches. Medical device product managers and sales executives in existing companies can increase market adoption rates through addressing reimbursement issues as part of the pre-sale activities. In this session, participants learned about common issues related to medical device reimbursement and the strategies that have been employed to improve market success. Presenters included David Barone and Yossi Elaz, both of Boston MedTech Advisors. Click here for more information about the event.
F.I.R.E. Series: "Crossing the Development Gap"
October 9, 2012
This month's presentation explored two potential sources of gap funding that you may not have known about. Michael Rusnak, Deputy Director of New Ventures & Technology Development and Associate Director for Biological Sciences in the Office of Technology Transfer, gave an overview of the University's Technology Development Fund. Additionally, Mikael Totterman, Chairman of Innovocracy, provided information about this emerging social funding source.
October 4, 2012-October 6, 2012
The Rochester Big Data Forum 2012 brought together renowned researchers from across the nation, leaders of federal research funding agencies, individuals representing high technology companies, and faculty and students from the University of Rochester for three days of presentations, discussions, and networking. Topics included predictive analytics; machine learning; computational physical, life, and social science; the semantic web; and more. The event was sponsored by the Office of the Dean of Arts, Science and Engineering; the Office of Research Alliances; Trustee Nomi (’85 and P’15) Bergman and Neal (P’15) Bergman; IBM; and Xerox. For more information about the forum, click here.
September 24, 2012 - September 25, 2012
This year's annual conference, "The Upside of Change: Succeeding in the Face of Uncertainty," addressed the pressing issues in the transformation of the healthcare market. Dr. Bradford Berk, CEO of the University of Rochester Medical Center, gave a presentation. For more information, click here.
High Tech Rochester Innovation Engineering Leadership Institute (IELI)
September 10, 2012-September 12, 2012
High Tech Rochester hosted an Innovation Engineering Leadership Institute (IELI). This two-and-a-half day training session was an opportunity to learn about various innovation tools that can help organizations create, communicate, and commercialize new ideas.
August 14, 2012
The University-Industry Demonstration Partnership (UIDP) hosted a University Technology Showcase Webinar Series. This webinar featured faculty presentations from the University of Rochester Medical Center, including:
- "Clinical and Translational Science Institute (CTSI) Overview and Accomplishments" (Dr. Thomas Pearson)
- "Regional Economic Development" (Peter Robinson and Jim Senall)
- "Pilot and Incubator Program Overview" (Dr. Randy Rosier)
- "In Vitro Model: 3D Bone Marrow Culture Bioreactor" and "In Vivo Model: Human TPO Receptor (c-Mpl) Knock-In Mouse Model" (Dr. Yuhchyau Chen)
- "Arrayed Imaging Reflectometry" (Dr. Benjamin Miller)
- "Implantable Living Cell-Based Biosensors for Real Time Monitoring" (Dr. Spencer Rosero)
- "The Quick Trainer" (Dr. Daniel Mruzek)
Click here to listen to the recorded webinar and to download the slide presentations.
June 29, 2012
The University of Rochester's Health Sciences Center for Computational Innovation sponsored a one-day joint meeting of scientists, engineers, and faculty from the University and IBM Research. The objective of the meeting was to bring together top research scientists from both institutions to discuss shared research interests and develop collaborative projects to be conducted with the support of the HSCCI and its resources. For more information, please click here.
June 25, 2012
This symposium featured lectures from URMC faculty members and trainees, as well as guests Dr. Vittorio Gallo and Dr. Robert Miller, two leading scientists in stem cell biology. For more information, click here.
June 14, 2012-June 15, 2012
The goal of this symposium was to promote the use of computational modeling approaches in immunology research and exchange research ideas and information of computational immunology among the immune modeling community and other related investigators. For more information, click here.
June 9, 2012
This event honored Dr. John M. Bennett’s 80th year and his dedication to leukemia research and community volunteerism for the arts. For more information, please click here.
June 5, 2012-June 7, 2012
IBM and the World Congress on Information Technology (WCIT) co-hosted the World Tech Jam, a free, global, digital brainstorming event where individuals shared their perspectives with global experts and decision makers. Topics of discussion included: collaborative healthcare; closing the global skills gap; sustainable urban living; energy, the environment, and sustainability; and media, arts, and culture in a digital world. For more information, click here.
June 1, 2012
This symposium introduced the field of pharmacometrics and discussed the role of modeling and simulation in drug discovery and development. The event provided an opportunity to hear from leaders in the field with backgrounds in industry and academia, as well as regulatory perspectives from the former head of the Division of Pharmacometrics at the Food and Drug Administration. It was sponsored by the University of Rochester Medical Center's Center for Human Experimental Therapeutics (CHET) and University at Buffalo School of Pharmacy and Pharmaceutical Sciences. For the full agenda, please click here.
May 31, 2012
Pathology Research Day included a poster session and six presentations. The Whipple Lecture, "Genetic Variation in Platelet Reactivity: Supervillins and RNAs Gone Wild," was given by Dr. Paul Bray. For the full agenda, please click here.
BioVenture Luncheon Series: "Sustainable Design for Medical Devices"
May 16, 2012
With increased social and regulatory pressures to reduce waste, particularly medical wastes, now is the time to understand and adopt sustainable practices for the design and manufacture of medical devices. This session included presentations from practitioners in academia and industry who shared their insights on practices that can be used to improve sustainability, as well as profitability, for new medical devices.
May 11, 2012
New York State Health Commissioner Dr. Nirav Shah delivered CEO Grand Rounds on May 11 at URMC. Dr. Shah's presentation, “Transforming Health Care: It’s Complicated," addressed reforming New York's Medicaid program and other major challenges ahead for health care. For more information, click here.
MedTech Institute: Bridging Regulatory Hurdles in the Growing Asia-Pacific Market
April 19, 2012
MedTech Institute hosted a one-day workshop on April 19th, focusing on regulatory compliance and strategies for bringing products to the Asia Pacific medical devices market.
April 10, 2012-April 13, 2012
The School of Nursing offered a free screening of TEDMED, a three-and-a-half-day meeting of the world's most creative minds and medicine's most innovative sciences. The live event took place in Washington, D.C., but URMC students, faculty, and staff viewied the simulcast in real time in Helen Wood Hall Auditorium (1W-304).
April 5, 2012
Researchers from the University of Rochester, RIT, Cornell and Clarkson displayed the innovative research they are doing and how it can help companies develop new products, processes, and services. The showcase gave university researchers the opportunity to learn about areas of interest to companies that can help guide future research. Representatives from the university technology transfer offices were on hand to discuss inventions already available for licensing. In addition, keynote speakers from leading NY State companies and development centers were on site to discuss the role of innovation in their organizations. For more information, click here.
February 6, 2012
William B. Bonvillian is Director of the Massachusetts Institute of Technology’s Washington, D.C. Office. On February 6, 2012, he presented, "The Organizational Challenge for Energy Technology Innovation" at the Rochester Institute of Technology. This talk detailed attempts to access evolving energy technology policy, focusing on the organizational challenges particularly at the federal government level. For more information, click here.
Process of Discovery Course: Dr. David Valle (Johns Hopkins University School of Medicine) Campus Visit
January 31, 2012
David Valle, MD, PhD, is the Director of the McKusick,-Nathans Institute of Genetic Medicine at Johns Hopkins University School of Medicine. He presented a lecture entitled, "The Quest to Find and Solve All Human Mendelian Disorders: Genomics Meets Genetics," as part of the Process of Discovery course on Tuesday, January 31st. For more information, click here.
January 30, 2012
William Gahl, MD, PhD, is the Clinical Director of the National Human Genome Research Institute at the National Institutes of Health. He presented a lecture entitled, "The National Institutes of Health - Undiagnosed Diseases Program," as part of the Process of Discovery course on Monday, January 30th, 2012. For more information, click here.
Dr. Kurt Schilling (Johnson & Johnson) Seminar on Leading Edge Trends in Medical Devices and Diagnostics
January 17, 2012
Kurt Schilling, PhD, is currently VP, Assay R&D at Ortho Clinical Diagnostics (OCD) at Johnson & Johnson, where he leads teams in Rochester, NY and Raritan, NJ involved in the development of medical diagnostic assays and platforms. He gave a seminar entitled, "Leading Edge Trends in Medical Devices and Diagnostics: Innovation at Johnson & Johnson Ortho Clinical Diagnostics" on Tuesday, January 17, 2012. This event was sponsored by the Biomedical Engineering Department, the Center for Emerging and Innovative Sciences, and the Office of Research Alliances. For more information, click here.
October 27, 2011
Ira Shoulson, M.D., Professor of Neurology, Pharmacology and Human Science, and Director of the Program for Regulatory Science and Medicine at Georgetown University, gave a presentation entitled, "Regulatory Science and Medicine: It's About Time!" on Thursday, October 27, 2011. The event was co-hosted by the Clinical and Translational Science Institute and the Office of Research Alliances. For more information, click here.
October 7, 2011
Dr. Allan Goldberg, Executive Director of Academic and Professional Affairs at Merck & Co., gave a presentation entitled, "Preclinical Drug Discovery and Development" on Friday, October 7, 2011. The event was co-hosted by the University Committee for Interdisciplinary Studies in Drug Discovery and the Office of Research Alliances. For more information, click here.
September 13, 2011
Dr. Lisa Porter, Director of the Intelligence Advanced Research Projects Activity (IARPA), gave a presentation entitled, "An Overview of IARPA" on Tuesday, September 13th at Rush Rhees Library. For more information about IARPA, click here.
July 29, 2011
Dr. John D. Obourn, Development Team Head at Pfizer, participated in a special research seminar on Friday, July 29th at the University of Rochester Medical Center. Dr. Obourn's presentation was entitled, "Developing New Medicines: The Process and The Chaos." The seminar was hosted by Richard Phipps, Ph.D., Dean's Professor of Environmental Medicine and Director of the Lung Biology Disease Program, and Scott Steele, Ph.D., Director of the Office of Research Alliances.
May 23, 2011
Frontiers in Materials Science for the 21st Century—Applications in Biomedicine Annual Symposium & Poster Session on Materials Research, sponsored by the UR Chapter of the Materials Research Society.
This full one-day symposium had the overarching theme of innovations in nanometer scale materials science and engineering, necessary to advance biological medicine in the coming decades. Keynote speakers addressed the problem from several perspective, including discussions of photoactive materials, nanometer scale extracellular environments, cell adhesion and signaling, biomimetic materials, and cellular regeneration. Contributed papers discussed biomedical and nanotechnological materials science research at the University of Rochester, as well as in the greater New York area. There was a "Gordon Conference" style format, in which a significant proportion of the conference was reserved for discussion and exchange of ideas.
May 6, 2011
The 23rd Annual URMC Genetics Day featured presentations by University of Rochester researchers engaged in biomedical and genetics research, a poster session and a keynote lecture by Dr. Keith Yamamoto.
April 21, 2011
The Center for Emerging and Innovative Sciences at the University of Rochester presented a lecture and panel discussion on the implications of the Stanford University v. Roche Molecular Systems case. This case, which is now before the U.S. Supreme Court, will attempt to resolve whether an individual inventor may unilaterally terminate a university's right under the Bayh-Dole Act relating to inventions arising from federally funded research. The case has wide ranging implications to universities, individual inventors, and companies licensing or considering licensing technologies from universities and other non-profit organizations.
CTSI Scientific Symposium: Applying Science to Health Care Reform
April 15, 2011
The University of Rochester Clinical and Translational Science Institute (CTSI) hosted an exciting, full-day symposium, entitled, "Applying Science to Health Care Reform." The symposium featured a wide range of presentations, including keynote presentations by Dr. Lawrence Tabak, Deputy Director of the National Institutes of Health (NIH), and Dr. Brian Mittman, Director of the Veterans Affairs (VA) Center for Implementation Practice and Research Support.
CTSB Opening Celebration
April 8, 2011
The University of Rochester Medical Center's new Clinical and Translational Building (CTSB) is the centerpiece of the CTSI's efforts to infuse fresh treatment and prevention insights into everyday patient care. This 200,000 square foot facility was funded, in large part, with $50 million in capital support from New York State. As one of the first buildings of its kind in the United States, the Clinical and Translational Science Building makes URMC a leader in applying biomedical research to improve not only our region's health, but also its economic vitality.
2011 CEIS University Technology Showcase
April 6, 2011
The Center for Emerging and Innovative Sciences (CEIS)* held its annual Technology Showcase on Wednesday, April 6th from 1pm to 6pm at the Doubletree Hotel in Rochester, NY. The theme for this year’s event was “Building an Innovation Economy in New York State." The Showcase provided a forum for participants from the business, academic, and government communities to learn about exciting new university research and technology, and to network with each other.
Dr. Jane Silverthorne (NSF) Campus Visit
February 15, 2011
Dr. Jane Silverthorne is the Deputy Division Director for Integrative Organismal Systems in the Directorate for Biological Sciences at the National Science Foundation. During her lecture, she provided a broad overview of current initiatives and activities at the NSF.
October 28-29, 2010
The Biomarkers and Biorepositories in Translational Research Symposium was held at the University of Rochester School of Medicine and Dentistry on October 28-29, 2010. The Symposium explored current opportunities and challenges in biomarker development and biobanking to address several disease areas. Various models of public-private partnerships designed to speed discovery and translational research were also discussed.
The event was co-sponsored by the Clinical and Translational Science Institute (CTSI) and the Office of Research Alliances (ORA).
October 11, 2010
Energy for the 21st Century 2010 was the second symposium sponsored by the University of Rochester’s Energy Research Initiative. Distinguished speakers from industry, government laboratories and academia shared their vision and were available for interactions. Scientists and engineers from the University of Rochester presented their research in talks and posters, and were available for discussions. Small and large companies will also had the opportunity to exhibit their products and services throughout the day.
April 13, 2010
John F. Elter, Ph.D., is the Empire Innovation Professor of Nanoengineering and the
Executive Director of the Center for Sustainable Ecosystem Nanotechnologies at the
College of Nanoscale Science and Engineering at SUNY Albany.
The Center for Sustainable Ecosystem Nanotechnologies at the College of Nanoscale Science and Engineering at SUNY Albany is a new organization whose mission is to apply nanotechnology to enable sustainable development. The seminar included an overview of the range of current research activities within the Center, as well a discussion of the unique opportunities for potential collaboration.
The seminar was sponsored by the Energy Research Initiative and the Office of Research Alliances.
October 22-23, 2009
The Genomics and Translational Medicine Symposium was held at the University of Rochester on October 22-23, 2009. The Symposium focused on topics in genomics and medicine, and included speakers from academia, government, and the private sector. The meeting was designed to explore the promise and challenges associated with personalized medicine, building on the University’s NIH Clinical and Translational Science Award and the recently established Clinical and Translational Science Institute at the University of Rochester.